178 related articles for article (PubMed ID: 19166339)
1. Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors.
Zhao L; Krishnan S; Zhang Y; Schenkman JB; Rusling JF
Chem Res Toxicol; 2009 Feb; 22(2):341-7. PubMed ID: 19166339
[TBL] [Abstract][Full Text] [Related]
2. Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors.
Krishnan S; Hvastkovs EG; Bajrami B; Choudhary D; Schenkman JB; Rusling JF
Anal Chem; 2008 Jul; 80(14):5279-85. PubMed ID: 18563913
[TBL] [Abstract][Full Text] [Related]
3. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
Boocock DJ; Maggs JL; Brown K; White IN; Park BK
Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of electrochemiluminescent metabolic toxicity screening arrays using a multiple compound set.
Pan S; Zhao L; Schenkman JB; Rusling JF
Anal Chem; 2011 Apr; 83(7):2754-60. PubMed ID: 21395325
[TBL] [Abstract][Full Text] [Related]
5. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
[TBL] [Abstract][Full Text] [Related]
6. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
[TBL] [Abstract][Full Text] [Related]
8. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
[TBL] [Abstract][Full Text] [Related]
9. High-throughput metabolic genotoxicity screening with a fluidic microwell chip and electrochemiluminescence.
Wasalathanthri DP; Malla S; Bist I; Tang CK; Faria RC; Rusling JF
Lab Chip; 2013 Dec; 13(23):4554-62. PubMed ID: 24113555
[TBL] [Abstract][Full Text] [Related]
10. Identification and mechanism of formation of potentially genotoxic metabolites of tamoxifen: study by LC-MS/MS.
Lim CK; Yuan ZX; Jones RM; White IN; Smith LL
J Pharm Biomed Anal; 1997 Jun; 15(9-10):1335-42. PubMed ID: 9226561
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
Mani C; Hodgson E; Kupfer D
Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
[TBL] [Abstract][Full Text] [Related]
12. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
14. Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved.
White IN; De Matteis F; Gibbs AH; Lim CK; Wolf CR; Henderson C; Smith LL
Biochem Pharmacol; 1995 Apr; 49(8):1035-42. PubMed ID: 7748182
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen metabolism in rat liver microsomes: identification of a dimeric metabolite derived from free radical intermediates by liquid chromatography/mass spectrometry.
Jones RM; Yuan ZX; Lim CK
Rapid Commun Mass Spectrom; 1999; 13(4):211-5. PubMed ID: 10097399
[TBL] [Abstract][Full Text] [Related]
16. Screening for reactive metabolites using electro-optical arrays featuring human liver cytosol and microsomal enzyme sources and DNA.
Zhao L; Schenkman JB; Rusling JF
Chem Commun (Camb); 2009 Sep; (36):5386-8. PubMed ID: 19724793
[TBL] [Abstract][Full Text] [Related]
17. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
Boocock DJ; Maggs JL; White IN; Park BK
Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
[TBL] [Abstract][Full Text] [Related]
18. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues.
Brown K; Brown JE; Martin EA; Smith LL; White IN
Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic electrochemical array for detection of reactive metabolites formed by cytochrome P450 enzymes.
Wasalathanthri DP; Mani V; Tang CK; Rusling JF
Anal Chem; 2011 Dec; 83(24):9499-506. PubMed ID: 22040095
[TBL] [Abstract][Full Text] [Related]
20. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
Malfatti MA; Ubick EA; Felton JS
Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
